Crete Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 06-07-2024
- Paid Up Capital ₹ 0.10 M
as on 06-07-2024
- Company Age 9 Year, 2 Months
- Last Filing with ROC 31 Mar 2022
- Revenue -12.86%
(FY 2021)
- Profit -267.98%
(FY 2021)
- Ebitda -143.55%
(FY 2021)
- Net Worth -95.26%
(FY 2021)
- Total Assets -0.38%
(FY 2021)
About Crete Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Shravan Tungenwar, Surendra Bhalekar, and Arunesh Balkashanmugam serve as directors at the Company.
- CIN/LLPIN
U24233MH2015PTC268969
- Company No.
268969
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Oct 2015
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Aurangabad, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Crete Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shravan Tungenwar  | Additional Director | 08-Jun-2021 | Current |
| Surendra Bhalekar | Director | 07-Oct-2015 | Current |
| Arunesh Balkashanmugam | Director | 07-Oct-2015 | Current |
Financial Performance of Crete Pharma.
Crete Pharma Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 12.86% decrease. The company also saw a substantial fall in profitability, with a 267.98% decrease in profit. The company's net worth observed a substantial decline by a decrease of 95.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Crete Pharma?
In 2021, Crete Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Vibgyor Life Sciences LlpActive 11 years 8 months
Surendra Bhalekar and Arunesh Balkashanmugam are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Crete Pharma?
Unlock and access historical data on people associated with Crete Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Crete Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Crete Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
